Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma
Jamie Messer(Pennsylvania State University), Jay D. Raman(Penn State Milton S. Hershey Medical Center), Yair Lotan(Southwestern Medical Center), Robert G. Uzzo(American Urological Association), Douglas S. Scherr(Cornell University), Scott E. Eggener(University of California, Los Angeles), John D. Terrell(The University of Texas Southwestern Medical Center), Steven Lucas(The University of Texas Southwestern Medical Center), Casey K. Ng(NewYork–Presbyterian Hospital), Stephen A. Boorjian(Mayo Clinic), Shahrokh F. Shariat(Universitätszahnklinik Wien), Michael Herman(Borland Groover Clinic), Mark Wille(University of Chicago), Benjamin Scoll(University of Pennsylvania)
Urologic Oncology Seminars and Original Investigations
September 10, 2011
Cited by 93
Related Papers
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381
Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins
|The Journal of Urology|2012|359
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359
Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma
|Circulation|2001|347